Mid Cap 09 Feb 2012, 04:46 PM
Sun Pharmaceutical Inds. Ltd.
CLSA
|
Price when Post 542.75 |
Target Price 565 |
Return 4.0995% |
For full report |
CLSA's call on Sun Pharma: outperform
Valuations towards higher end. Trading at higher end of its PE (price earnings) band. See risks to earnings growth at Taro. Risk to earnings could come from a potential increase in tax rate.